AGIO Live signals | Maximize Profits with Getagraph.com

BUY 93124 min ago

@ $25.84

Issued: 14 Feb 2024 @ 13:56

Return: 13.89%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 1.31 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology...

Stats
Today's Volume	549 245
Average Volume	805 474
Market Cap	1.64B
EPS	$-1.720 ( 2024-02-21 )
Next earnings date	( $-1.640 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.51
ATR14	$0.0300 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Fouse Jacqualyn A	Buy	15 934	Common stock
2024-04-10	Fouse Jacqualyn A	Sell	7 791	Common stock
2024-04-08	Fouse Jacqualyn A	Sell	15 934	Restricted stock units
2024-03-07	Foster-cheek Kaye I	Sell	1 285	Common stock
2024-03-05	Foster-cheek Kaye I	Sell	300	Common stock

INSIDER POWER
24.98
Last 100 transactions
Buy: 882 792 \| Sell: 538 174

Volume Correlation

Long: -0.22 (neutral)

Short: -0.75 (moderate negative)

Signal:(37.237) Neutral

Agios Pharmaceuticals Inc Correlation

10 Most Positive Correlations
NEOG	0.95
LSXMA	0.941
EAR	0.94
VORB	0.94
LSXMK	0.94
STAF	0.938
VERU	0.936
TTOO	0.936
OCC	0.935
ACCD	0.935

10 Most Negative Correlations
EBSB	-0.952
PAE	-0.944
RMRM	-0.935
THRN	-0.933
SERA	-0.925
CYT	-0.924
BWC	-0.921
ZGNX	-0.919
MLTX	-0.919
GXII	-0.918

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Agios Pharmaceuticals Inc Correlation - Currency/Commodity

-0.19
( neutral )

-0.24
( neutral )

0.00
( neutral )

-0.03
( neutral )

0.62
( weak )

0.24
( neutral )

Agios Pharmaceuticals Inc Financials

Annual	2023
Revenue:	$26.82M
Gross Profit:	$17.32M (64.57 %)
EPS:	$-6.33

Q4	2023
Revenue:	$7.10M
Gross Profit:	$5.11M (72.00 %)
EPS:	$-1.720

Q3	2023
Revenue:	$7.40M
Gross Profit:	$6.77M (91.44 %)
EPS:	$-1.640

Q2	2023
Revenue:	$6.71M
Gross Profit:	$5.60M (83.49 %)
EPS:	$-1.510

Financial Reports:

No articles found.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.